vs
Side-by-side financial comparison of iQSTEL Inc (IQST) and Phathom Pharmaceuticals, Inc. (PHAT). Click either name above to swap in a different company.
iQSTEL Inc is the larger business by last-quarter revenue ($84.2M vs $57.6M, roughly 1.5× Phathom Pharmaceuticals, Inc.). On growth, Phathom Pharmaceuticals, Inc. posted the faster year-over-year revenue change (94.1% vs -14.9%). iQSTEL Inc produced more free cash flow last quarter ($-1.2M vs $-167.0M).
iQSTEL Inc is a technology holding company operating three core segments: telecommunications, Internet of Things (IoT), and fintech. It offers connectivity services, smart IoT monitoring solutions, and digital financial tools, mainly serving small and medium-sized enterprises and retail customers in North and South American markets.
Phathom Pharmaceuticals is a clinical-stage biopharmaceutical firm focused on developing and commercializing innovative therapies for gastrointestinal diseases. Its lead product candidates address acid-related disorders, inflammatory bowel disease, and other GI conditions, serving patients mainly across North America and Europe.
IQST vs PHAT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $84.2M | $57.6M |
| Net Profit | $-2.7M | — |
| Gross Margin | 3.5% | 86.7% |
| Operating Margin | -2.9% | — |
| Net Margin | -3.2% | — |
| Revenue YoY | -14.9% | 94.1% |
| Net Profit YoY | -44.5% | 71.6% |
| EPS (diluted) | $-0.92 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $84.2M | $57.6M | ||
| Q3 25 | $102.9M | $49.5M | ||
| Q2 25 | $72.2M | $39.5M | ||
| Q1 25 | $57.6M | $28.5M | ||
| Q4 24 | $98.9M | $29.7M | ||
| Q3 24 | $54.2M | $16.4M | ||
| Q2 24 | $78.6M | $7.3M | ||
| Q1 24 | $51.4M | — |
| Q4 25 | $-2.7M | — | ||
| Q3 25 | $-2.3M | $-30.0M | ||
| Q2 25 | $-2.3M | $-75.8M | ||
| Q1 25 | $-1.1M | $-94.3M | ||
| Q4 24 | $-1.9M | — | ||
| Q3 24 | $-773.0K | $-85.6M | ||
| Q2 24 | $-2.0M | $-91.4M | ||
| Q1 24 | $-580.2K | — |
| Q4 25 | 3.5% | 86.7% | ||
| Q3 25 | 2.7% | 87.5% | ||
| Q2 25 | 2.6% | 87.2% | ||
| Q1 25 | 3.4% | 86.9% | ||
| Q4 24 | 2.7% | 87.1% | ||
| Q3 24 | 3.7% | 85.6% | ||
| Q2 24 | 2.8% | 81.2% | ||
| Q1 24 | 2.7% | — |
| Q4 25 | -2.9% | — | ||
| Q3 25 | -0.5% | -30.8% | ||
| Q2 25 | -0.9% | -151.7% | ||
| Q1 25 | -1.0% | -276.5% | ||
| Q4 24 | -0.3% | — | ||
| Q3 24 | -0.1% | -433.0% | ||
| Q2 24 | -0.4% | -1055.4% | ||
| Q1 24 | -0.4% | — |
| Q4 25 | -3.2% | — | ||
| Q3 25 | -2.3% | -60.5% | ||
| Q2 25 | -3.3% | -191.9% | ||
| Q1 25 | -2.0% | -330.7% | ||
| Q4 24 | -1.9% | — | ||
| Q3 24 | -1.4% | -523.3% | ||
| Q2 24 | -2.5% | -1248.6% | ||
| Q1 24 | -1.1% | — |
| Q4 25 | $-0.92 | — | ||
| Q3 25 | $-0.68 | $-0.41 | ||
| Q2 25 | $-0.82 | $-1.05 | ||
| Q1 25 | $-0.44 | $-1.31 | ||
| Q4 24 | $-1.19 | — | ||
| Q3 24 | $-0.40 | $-1.32 | ||
| Q2 24 | $-0.90 | $-1.56 | ||
| Q1 24 | $-0.37 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.2M | $130.0M |
| Total DebtLower is stronger | $4.1M | $209.1M |
| Stockholders' EquityBook value | $16.3M | $-438.2M |
| Total Assets | $51.1M | $259.1M |
| Debt / EquityLower = less leverage | 0.25× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.2M | $130.0M | ||
| Q3 25 | $2.3M | $135.2M | ||
| Q2 25 | $2.0M | $149.6M | ||
| Q1 25 | $1.1M | $212.3M | ||
| Q4 24 | $2.5M | $297.3M | ||
| Q3 24 | $2.1M | $334.7M | ||
| Q2 24 | $797.2K | $276.2M | ||
| Q1 24 | $2.7M | — |
| Q4 25 | $4.1M | $209.1M | ||
| Q3 25 | $2.7M | $207.1M | ||
| Q2 25 | $4.5M | $205.1M | ||
| Q1 25 | $3.5M | $203.2M | ||
| Q4 24 | $2.5M | $201.4M | ||
| Q3 24 | $3.2M | $175.7M | ||
| Q2 24 | $2.5M | $174.4M | ||
| Q1 24 | $194.0K | — |
| Q4 25 | $16.3M | $-438.2M | ||
| Q3 25 | $17.9M | $-422.5M | ||
| Q2 25 | $14.3M | $-405.8M | ||
| Q1 25 | $11.6M | $-338.4M | ||
| Q4 24 | $11.9M | $-253.6M | ||
| Q3 24 | $8.1M | $-187.1M | ||
| Q2 24 | $7.6M | $-233.8M | ||
| Q1 24 | $8.4M | — |
| Q4 25 | $51.1M | $259.1M | ||
| Q3 25 | $46.9M | $240.3M | ||
| Q2 25 | $51.4M | $250.2M | ||
| Q1 25 | $42.0M | $294.2M | ||
| Q4 24 | $79.0M | $378.3M | ||
| Q3 24 | $32.4M | $387.0M | ||
| Q2 24 | $30.0M | $319.4M | ||
| Q1 24 | $22.1M | — |
| Q4 25 | 0.25× | — | ||
| Q3 25 | 0.15× | — | ||
| Q2 25 | 0.31× | — | ||
| Q1 25 | 0.31× | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 0.40× | — | ||
| Q2 24 | 0.34× | — | ||
| Q1 24 | 0.02× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.2M | $-166.8M |
| Free Cash FlowOCF − Capex | $-1.2M | $-167.0M |
| FCF MarginFCF / Revenue | -1.5% | -290.0% |
| Capex IntensityCapex / Revenue | 0.0% | 0.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-4.0M | $-328.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.2M | $-166.8M | ||
| Q3 25 | $-953.0K | $-14.1M | ||
| Q2 25 | $257.7K | $-62.7M | ||
| Q1 25 | $-1.9M | $-84.9M | ||
| Q4 24 | $-403.7K | $-266.8M | ||
| Q3 24 | $625.0K | $-63.6M | ||
| Q2 24 | $-2.6M | $-70.7M | ||
| Q1 24 | $-536.9K | — |
| Q4 25 | $-1.2M | $-167.0M | ||
| Q3 25 | $-969.2K | $-14.1M | ||
| Q2 25 | $211.7K | $-62.8M | ||
| Q1 25 | $-2.0M | $-84.9M | ||
| Q4 24 | $-421.3K | $-266.9M | ||
| Q3 24 | $594.5K | $-63.6M | ||
| Q2 24 | $-2.6M | $-70.8M | ||
| Q1 24 | $-608.5K | — |
| Q4 25 | -1.5% | -290.0% | ||
| Q3 25 | -0.9% | -28.6% | ||
| Q2 25 | 0.3% | -159.0% | ||
| Q1 25 | -3.4% | -297.9% | ||
| Q4 24 | -0.4% | -899.8% | ||
| Q3 24 | 1.1% | -389.0% | ||
| Q2 24 | -3.4% | -966.2% | ||
| Q1 24 | -1.2% | — |
| Q4 25 | 0.0% | 0.4% | ||
| Q3 25 | 0.0% | 0.1% | ||
| Q2 25 | 0.1% | 0.2% | ||
| Q1 25 | 0.1% | 0.1% | ||
| Q4 24 | 0.0% | 0.5% | ||
| Q3 24 | 0.1% | 0.3% | ||
| Q2 24 | 0.0% | 0.6% | ||
| Q1 24 | 0.1% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IQST
| USA | $53.2M | 63% |
| Other | $29.9M | 35% |
| Switzerland | $1.1M | 1% |
PHAT
Segment breakdown not available.
